DPhil Students: Carl welcomes informal contacts from students in the field of evidence-based medicine
The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare.
MSc in EBHC
Training and nurturing the next generation of global leaders in evidence, across a diverse range of qualifications, to inform better health care.
Catalog of Bias
A collaborative project mapping all the biases that affect health evidence
Global Centre for Healthcare and Urbanisation
seeks to make urban centres environmentally, economically, and socially sustainable, and to provide an environment that supports and sustains health and wellbeing.
Trust the Evidence
Discussing the latest research evidence to inform healthcare decisions
BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of CEBM & Programs in EBHC
- NHS Urgent Care GP
- Co-Director Global Centre for Healthcare & Urbanisation
Carl Heneghan is a clinical epidemiologist with expertise in evidence-based medicine, research methods, and evidence synthesis expertise.
He has over 400 peer-reviewed publications (current H index 82); published 110 systematic reviews.
His work includes investigating the evidence for approval of drugs and devices, assessing health claims and researching common presenting conditions in the community.
He has investigated antivirals Tamiflu, acute respiratory infections and the transmission of SARs-CoV-2. He has expertise in medical device regulation, diagnosis and screening and avoidable le harms.
Impact projects include the COVID-19 Evidence Service, anticoagulation care, Primodos & congenital malformations, the harms of transvaginal mesh and the transmission of SARs-CoV-2 (see cebm research)
He is a clinical advisor to two UK All Parliamentary Party Groups, an adviser to the WHO clinical trials registry platform and a founder of the AllTrials campaign; twice he was voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status.
In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching. He is the Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM and is Director of Programs in Evidence-Based Health Care,
Dissemination and Media: See find an expert page
He regularly podcasts his talks on iTunes, has an active Twitter account @carlheneghan, is a columnist for the Spectator and writes regularly at trusttheevidence.substack.com
Global Centre for Healthcare and Urbanisation (GCHU)
He is co-director of the GCHU based at Kellogg College, which has been established to foster a better understanding of the interaction between healthcare and urbanisation.
Conflicts of interest and payments:
He holds grant funding from the NIHR School of Primary Care Research, the NIHR BRC Oxford, and the World Health Organization for a series of Living rapid reviews on the modes of transmission of SARs-CoV-2 reference WHO registration No2020/1077093. He has received financial remuneration from an asbestos case and given legal advice on mesh, hormone pregnancy tests and Sodium Valproate. He receives expenses and payments for his media work. He receives expenses for teaching EBM, and his GP work out of hours in NHS. He has received income from the publication of a series of toolkit books for appraising treatment recommendations in non-NHS settings and evidence reviews. He is an advisor to Collateral Global, the Sir James Mackenzie Institute for Early Diagnosis at St Andrew's University, and the WHO's International Clinical Trials Registry Platform (ICTRP) and is a member of the Board of Preventing Overdiagnosis. He is also the co-director of the Global Centre for Healthcare and Urbanisation.
Brodersen J. et al, (2018), BMJ evidence-based medicine, 23, 1 - 3
Nunan D. et al, (2017), Evidence-Based Medicine, 22, 202 - 204
Hayward GN. et al, (2017), JAMA - Journal of the American Medical Association, 317, 1535 - 1543
France HS. et al, (2023), Drug safety
McLellan J. et al, (2023), BMJ Open, 13, e065748 - e065748
Thomas ET. et al, (2022)